MBRX - 2.50 Pre-market now at 2.66/2.85 Moleculin to Collaborate on Combining its WP1122 Brain Cancer Drug Candidate with Roche's Drug Avastin http://stockcharts.com/c-sc/sc?s=MBRX&p=D&b=5&g=0&i=t07879269212&r=1504699935797 http://stockcharts.com/c-sc/sc?s=MBRX&p=W&b=5&g=0&i=t44512568469&r=1504699920789